We are delighted to support the US based Institute for Clinical and Economic (ICER) in launching a dedicated interactive modelling platform hosting a wide variety of cost-effectiveness and budget impact models developed by ICER and their partner academic modelling groups. We strongly believe that this modelling platform has the potential to substantially advance users’ understanding of the health economic models and specifically bring more clarity to the relation between inputs and the results as well as to improve an overall clarity and transparency around cost-effectiveness models.
This article is inspired by the exciting idea of data interoperability in health economics modelling process, which means sourcing (fetching) inputs for models in real-time, using modern software infrastructure capabilities. On a larger scale, development of naming conventions for health economic model inputs would be required, so this is also a call for action for researchers working in the health economics modelling domain.
Interoperability – the ability of computer systems or software to exchange and make use of information.
Most of the modellers and consultants working in the field of Health Technology Assessment (HTA) and economic evaluations of healthcare technologies are familiar with the labour intensive process of manual updates/localisation in cost-effectiveness or a budget impact model. In particular, the treatment effect data needs to be validated and approved by multiple parties before it is published and used as a model input to project future health and cost outcomes beyond the lifespan of a clinical study.
It has taken us some quite years to develop and release our new eModels Platform for health economics models and global value dossier (GVD) creation, adaptation and value communications. This new integrated solution offers a suite of functionality for complete editorial control and global-to-local adaptation and usage analytics of cost-effectiveness and budget health economics models and value demonstration tools.
We are delighted to continue our ongoing participation at ISPOR as exhibitors and short-course instructors. Join our booth (C4-091) to learn more about our innovative technology solutions for value evidence communication and data collection. we’d be happy to share our knowledge in the space of optimisation and fiscal modelling as presented in our ISPOR short-course “Alternative Economic Assessment for Expressing Healthcare Value and Informing Resource Allocation Decisions” that we are teaching on Sunday afternoon.
Digital Health Outcomes & Global Market Access Team
This year at ISPOR our team of health economists and software specialists will be presenting new solutions developed to accelerate market access and research. We are proud to present our eModels builder platform designed to scale the development of interactive health economics models customer facing tools. Apart from this we will be presenting the range of software solutions for ePRO and patient level data collection. Another new and exiting field of our work is data mining algorithms for creation of proprietary databases constituting from a mixture of private and public data.
Join our booth to learn more and discover how custom software solution can help you accelerate product launch.
With best wishes,
Digital Health Outcomes Team
Join our booth number 215 to learn more about the digital tools and alternative approaches to express healthcare value. We are exhibiting with our partner company Global Market Access Solutions (GMAS) and jointly running a short course “Alternative Economic Assessment For Expressing Healthcare Value And Informing Resource Allocation Decisions”.
We invite all friends, clients and partners to join drinks reception held at our booth during Tuesday evening poster session.
DHO & GMAS team
In recent years multi-criteria decision analysis (MCDA) has gained interest in healthcare, particularly as a potential methodology for assessing the value drugs. Several frameworks and methodologies have been proposed for developing MCDA tools. However, there is no consensus on the weighting that each criterion should be allocated. This primary data collection tool sought to obtain feedback on the weighting of criteria from clinicians, health economists, insurers, payers, patients and the public. The objective of this survey, which is ongoing, is to establish the weighting preferences of criteria for assessing the value of drugs from people from all walks of life.
By clicking here you can view the MCDA weights data collected from 75+ respondents during ISPOR meeting in Glasgow. Once you submit your data, it will be compared to the pooled results of other respondents. Thank you for your participation! We acknowledge your contribution to the global MCDA weights knowledge base. Survey results will be shared with all respondents.
Join our booth number 111 to learn more about the innovative digital tools for health economics and market access. This year we are exhibiting at ISPOR together with our partner company Global Market Access Solutions (GMAS) and offering a unique mix of content development and digital services. Meet our team if you are interested to learn more about interactive health economics models, digitised value narrative, global market access platforms, apps for data gathering and ePRO and other custom solutions for health data collection, processing and visualisation.
Separately we are proud to announce our new MCDA tool designed to collect weights of MCDA criteria worldwide! Please join us to contribute to the survey, all results will be shared with participants.
Join us for drinks and warm atmosphere on Tuesday, 7th of Nov at 18:00, at our booth number 111.
Mobile apps and study portals with CFR 21 Part 11 compliance, infrastructure, and process, developed specifically for the biopharma R&D organisation. Meet us at ISPOR in Boston to learn more about our mClinical Research software and consulting offerings.
Please pass by our Digital Health Outcomes booth #415 to speak about approaches to accelerating digital transformation in your organisation. Our team of experts will be presenting market access support platforms, interactive health economics models, value tools and other technology and design solutions for health economics, clinical and regulatory needs.
Apart from our core modelling, data and value story visualisation services and tools for Market Access and HEOR we will be presenting a set of new solutions for Electronic Data Capture and ePRO powered by mHealth apps.